The role of Siemens Healthineers in the COVID-19 pandemic
Developing solutions and supporting clinical settings

Jul 01, 2020

A message from Peter Harrison, Managing Director GB&I

The COVID-19 pandemic continues to provide a challenge for many of us, having caused significant disruption to both our personal and professional lives. The progress made in tackling the disease, however, is testament to how well we have adapted to this challenging situation. Of course, we must continue to remain vigilant, and we work closely with our customers in Great Britain and Ireland as the challenges we all face continue to evolve.

Yet positives also emerge during times of crisis. The importance of digitalisation in healthcare has never been clearer to see, with adoption of remote and smart technologies on the rise. A partnership approach to working with healthcare providers has also been present throughout – from our customer service and enterprise service teams working hand in hand with customers, to our voluntary participation in the Ventilator Challenge UK, supporting ventilator manufacturers to scale up production in a time of great need*.

At Siemens Healthineers, we are proud to be an integral part of the solution. The resilience of our people, combined with the innovation of our technology, and flexibility of our service offering has placed us in good stead in the battle against COVID-19. Rest assured that our commitment to supporting this battle is steadfast; we continue to work diligently to meet our customers’ evolving needs.

*Siemens Healthineers does not manufacture ventilators nor do ventilators feature within our product portfolio

Scroll through to see how we're aiding the fight against COVID-19

POC Testing
Remote scanning
Enterprise services
Research & Innovation
Computed Tomography

Diagnosis of COVID-19 and the role of Computed Tomography

CT scanners have been employed in the response to COVID-19 since the initial build of the Red Cross Hospital in Wuhan, with high resolution imaging, such as that enabled by the SOMATOM go.Top, SOMATOM go.All and SOMATOM X.cite – facilitating both diagnosis and evaluation of disease.

We have delivered the first CT container solution to North Tees and Hartlepool NHS Foundation Trust, offering a separate environment for the scanning of non-COVID related examinations. Read the press release.

Our response to the COVID-19 pandemic: CT

Bedside ultrasound to diagnose lung pathology and for vascular access in COVID-19 patients

Siemens Healthineers ultrasound machines and sonography equipment address the complex clinical requirements of COVID-19 – enabling cost-effective, early diagnosis of pneumonia without radiation exposure.

Portable systems such as the ACUSON Juniper, ACUSON P500 and ACUSON Freestyle (cable-free ultrasound) are helpful in evaluating pleural abnormalities, detecting catheter malposition and treating pleural effusion1,2,3.

Lung Ultrasound - Quick Reference Card

Utilising Ultrasound for COVID-19
Laboratory Diagnostics

Laboratory Diagnostics: answering the call on SARS-CoV-2 and COVID-19

Fast, accurate screening and monitoring are essential for the disease management of COVID-19 and our diagnostics solutions in infectious disease, haematology, blood gas and other laboratory tests are at the disposal of our customers and partners.

We have expanded infectious-disease testing capabilities by developing a SARS-CoV-2 laboratory serology assay4 to detect presence of IgM and IgG antibodies in blood. This reveals if a person had COVID-19 even if they were asymptomatic or undiagnosed.
Answering the call to address the COVID-19 pandemic
Cios Alpha

Easy handling, smooth workflow

Cios Alpha is designed for ease of use and less distractions in workflows. Its straightforward system and software design reduces the hassle around the equipment – and allows you to fully focus on what you need to do.

Maintain the highest infection control standards
  • Anti-microbial surface and washable mouse5
  • Makes cleaning and disinfection as easy as possible
  • Reduces microbial growth on the system
Explore Cios Alpha
Point-of-Care Testing

Blood gas testing at the point-of-care

Blood gas analysis provides rapid information on a patient’s oxygenation, pulmonary function, acid-base balance and metabolic status. Critically ill patients requiring ventilation should be monitored with blood gas analysis in order to personalise ventilator settings. 

We have two key blood gas analysis solutions:
Point-of-care critical care solutions
Siemens Healthineers X-ray

Mobile chest X-ray for COVID-19 ICU patients

The COVID-19 pandemic is placing increased demand on X-ray services within NHS hospitals around the UK. To meet this need, it is essential to have flexible, powerful resources that can be used at the patient's bedside when needed.
The MOBILETT Elara Max offers mobility and positioning flexibility even in tight spaces, with superb image quality. Whilst the MOBILETT XP Hybrid combines imaging power, quality and mobility. Polymobil Plus offers mobile versatility for a multitude of applications.
Our response to the COVID-19 pandemic: X-ray
Siemens Healthineers syngo Virtual Cockpit

Remote support: Sharing knowledge from a distance

syngo Expert-i and syngo Virtual Cockpit allows remote radiographic staff to share knowledge and connect virtually with on-site radiographers in real time providing comprehensive scanning assistance and specialist or training knowledge. Smart Remote Support enables a live connection between your system and our team to provide you with technical and clinical application support when you need it. Our online learning portfolio is continually evolving.
Siemens Healthineers Fluoroscopy

Configuring fluoroscopy systems at a time of high demand

The Artis zee multi-purpose fluoroscopy system can be configured to perform a standard chest X-ray to support X-ray services in a time of high demand during the ongoing COVID-19 pandemic.

The Clinical Application Support team can assist you with this if required by connecting remotely and adding the appropriate protocol.
Siemens Healthineers Enterprise Services

Support beyond technology

Our Enterprise Services team is engaged in long-term partnerships with many NHS trusts, complementing state-of-the-art technology with services in operations management, facility design and healthcare consulting.

Our UK-wide network of experts can support the NHS to:
  • Optimise pathways and streamline operations while safeguarding patient experience
  • Expand capabilities to meet the urgent demand for care
  • Advance quality and precision of care – deploying innovation where relevant
Learn how we create value partnerships
Siemens Healthineers Research and Development team

Research & Innovation Support

The Research and Innovation team is engaged in partnerships with NHS trusts and Universities, where there are ongoing research activities. The team are interested in understanding the current unmet needs of the NHS and can engage in areas such as:
  • Short term solutions for COVID-19 diagnostics
  • Support efficient operating procedures in telehealth settings
  • Support for patients to actively participate in their care
  • Developing AI-enabled tools to prioritise and streamline workloads
Learn more

Press & Statements


GB&I Statement - COVID-19 Business Impact

Siemens Healthineers is continuously assessing the impact of the COVID-19 pandemic and adapting our business operations in line with government guidance within England, Ireland and the devolved nations. We continue to deliver both essential and critical support services, working closely with the NHS, HSE and other care providers as well as our industry partners.
Read the full statement

Customer Service operations

Siemens Healthineers is dedicated to providing a high level of support during these uncertain times. Please read our statement below regarding our Customer Service operations during the COVID-19 pandemic.
Read the statement

COVID-19: open letter from Bernd Montag

9th April 2020: Statement from CEO, Bernd Montag, on the current situation around COVID-19
Read the open letter

CT container solution safely boosts imaging capacity at North Tees and Hartlepool NHS Foundation Trust

The first CT container solution from Siemens Healthineers was delivered to North Tees and Hartlepool NHS Foundation Trust, where the additional Computed Tomography scanner offers a separate environment for the scanning of non-COVID related examinations.
Read the press release

SARS-CoV-2 antibody test from Siemens Healthineers found to satisfy mass screening criteria in Public Health England evaluation

New SARS-CoV-2 total antibody tests are appraised by Public Health England (PHE) in a new head-to-head evaluation of commercial tests in the UK.
Read the press release

Siemens Healthineers now shipping worldwide total antibody test and molecular test kit for COVID-19 with expanded capacity

Siemens Healthineers announced today that it is now shipping worldwide its laboratory-based total antibody test6 to detect the presence of SARS-CoV-2 IgM and IgG antibodies in blood. The test received the CE mark and data has demonstrated 100 percent sensitivity7 and 99.8 percent specificity.
Read the press release

Siemens Healthineers starts delivery of test kit for coronavirus SARS-CoV-2, now CE-IVD Registered

Siemens Healthineers registered its molecular Fast Track Diagnostics (FTD) SARS-CoV-2 Assay test kit for diagnostic use allowing for immediate rollout of the testing kit for diagnostic use in Europe.
Read the press release

Siemens Healthineers to expand SARS-CoV-2 testing to include a total antibody test

Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic.
Read the press release

Get in touch

For any questions, please click below to reach out to the press office.

Related Articles


2Reusz G, Csomos A, The role of ultrasound guidance for vascular access. Curr Opin Anaesthesiol. 2015 Dec;28(6):710-6. doi:


4In development; not available for sale. Future availability cannot be guaranteed.


6CE-marked for sale in the EU. This test has not been reviewed by the FDA. In the US, use of this test is limited to laboratories that are certified under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform high-complexity testing. Product availability may vary by country and is subject to regulatory requirements.

7≥ 14 days post-PCR positive test